PCN13 Quality-of-Life (QOL) Results from the Phase 3 Rainbow-ASIA Study of Ramucirumab PLUS paclitaxel (RAM/PTX) Versus Placebo PLUS paclitaxel (PBO/PTX) in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (AGC).

Subjects

Subjects :

*ESOPHAGOGASTRIC junction
*CARBOPLATIN
*QUALITY of life
*PACLITAXEL
*PLACEBOS
*ADENOCARCINOMA

Details

Language :

English

ISSN :

10983015

Volume :

24

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

150694119

Full Text :

https://doi.org/10.1016/j.jval.2021.04.105